Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aerpio Pharmaceuticals, Inc. | Director | Common Stock | 16.2K | $33.3K | $2.06 | Jun 30, 2021 | Direct |
MEI Pharma, Inc. | Director | Stock Option (Right to Buy) | 87.5K | Jul 5, 2022 | Direct | ||
ImmunityBio, Inc. | Director | Stock Option (right to buy) | 77.6K | Jun 11, 2024 | Direct | ||
Celldex Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 16.5K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
IBRX | ImmunityBio, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
CLDX | Celldex Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
IBRX | ImmunityBio, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
MEIP | MEI Pharma, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 7, 2022 | Director |
CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 0 | $0 | 3 | Jun 17, 2022 | Director |
IBRX | ImmunityBio, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
IBRX | ImmunityBio, Inc. | Aug 20, 2021 | 2 | -$250K | 4 | Aug 24, 2021 | Director |
IBRX | ImmunityBio, Inc. | Aug 17, 2021 | 2 | -$461K | 4 | Aug 19, 2021 | Director |
MEIP | MEI Pharma, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Director |
AADI | Aerpio Pharmaceuticals, Inc. | Jun 30, 2021 | 1 | $12.4K | 4 | Jul 2, 2021 | Director |
AADI | Aerpio Pharmaceuticals, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
IBRX | ImmunityBio, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |